494 results on '"Rohatgi, Anand"'
Search Results
52. High‐Density Lipoprotein is Independently Associated with Muscle Mitochondrial Function in Healthy Humans
53. Abstract 498: HDL Containing Specific Proteins Blunts The Association With Cholesterol Efflux Capacity: Observations From The Dallas Heart Study
54. Abstract 427: Extreme Low Cholesterol Efflux Is Linked More Strongly To Worse Anti-oxidative Function Than With Systemic Inflammation
55. Abstract 400: Cardiometabolic Profile Of Haptoglobin Genotype In A Multi-Ethnic Diabetes Cohort
56. Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population
57. Sex-Based Differences in Cardiometabolic Biomarkers
58. Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?
59. The association of abnormal findings on transthoracic echocardiography with 2011 Appropriate Use Criteria and clinical impact
60. Abstract P175: Combined Metabolic Health And Obesity Status Is Associated With Markers Of High-Density Lipoprotein Metabolism: Dallas Heart Study
61. Supplement to: HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
62. Lifetime Risks for Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at Ages 45, 55, and 65 Years in Men: The Cooper Center Longitudinal Study
63. Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure
64. Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity
65. The Role of Advanced Lipid Testing in the Prediction of Cardiovascular Disease
66. Modulating cholesterol efflux capacity to improve cardiovascular disease
67. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)
68. HDL Cholesterol Efflux Capacity and Cardiovascular Events
69. HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
70. HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
71. Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease
72. USING READILY AVAILABLE CLINICAL INFORMATION TO IDENTIFY INDIVIDUALS WITH HIGH LIPOPROTEIN A LEVELS: THE DALLAS HEART STUDY
73. Association of troponin T detected with a highly sensitive assay and cardiac stricture and mortality risk in the general population
74. Capítulo 6 - Lipoproteínas de alta densidad y colesterol unido a lipoproteínas de alta densidad
75. The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study
76. Effects of the Thiazolidinedione Medications on Micro- and Macrovascular Complications in Patients with Diabetes—Update 2008
77. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
78. Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
79. An Association Between the Inflammatory Biomarker GlycA and Depressive Symptom Severity
80. Appropriate Use and Clinical Impact of Transthoracic Echocardiography
81. Discordant effects of rosiglitazone on novel inflammatory biomarkers
82. Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction
83. AN HDL PROTEOMIC SCORE INDEPENDENTLY PREDICTS INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.
84. Clinical applications of advanced lipoprotein testing in diabetes mellitus
85. Chapter 6 - High-Density Lipoprotein and High-Density Lipoprotein Cholesterol
86. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity
87. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
88. Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS
89. Elucidating the Link Between Alcohol and HDL Metabolism in the Multiethnic Dallas Heart Study
90. SOLUBLE FMS-LIKE TYROSINE KINASE-1 (SFLT-1) IS ASSOCIATED WITH SUBCLINICAL AND CLINICAL ASCVD: THE DALLAS HEART STUDY
91. INFLAMMATORY MARKER, GLYCA, OUTPERFORMS HSCRP IN PREDICTING CARDIOVASCULAR EVENTS
92. INFLUENCE OF POST-IMPLANTATION NON-FATAL ADVERSE EVENTS ON CONDITIONAL SURVIVAL IN PATIENTS WITH DURABLE LEFT VENTRICULAR ASSIST DEVICE SUPPORT FOR DESTINATION THERAPY
93. Body Size Misperception: A Novel Determinant in the Obesity Epidemic
94. Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
95. Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study
96. Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans
97. Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events
98. 8 - Lipid Measurements
99. Racial Differences in Cardiovascular Biomarkers in the General Population
100. NOVEL BIOMARKERS OF CORONARY ARTERY CALCIUM INCIDENCE OR PROGRESSION: INSIGHTS FROM THE DALLAS HEART STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.